I liked the efficacy slide. imagine how it would look with 100% of the recipients on full dose
also good to see that they are seeking pharmaceutical partners to invest in next stage of trials. if successful, it will reduce dilution and validate potential. won't happen until mid next year when full results are in.
- Forums
- ASX - By Stock
- ATX
- Ann: Update on ACCENT Trial in Pancreatic Cancer
Ann: Update on ACCENT Trial in Pancreatic Cancer, page-32
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATX (ASX) to my watchlist
|
|||||
Last
6.1¢ |
Change
-0.003(4.69%) |
Mkt cap ! $16.56M |
Open | High | Low | Value | Volume |
6.4¢ | 6.4¢ | 6.1¢ | $14.71K | 240.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6872 | 6.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.4¢ | 11099 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6872 | 0.061 |
2 | 96666 | 0.060 |
3 | 103326 | 0.059 |
1 | 85991 | 0.058 |
3 | 282105 | 0.057 |
Price($) | Vol. | No. |
---|---|---|
0.064 | 11099 | 1 |
0.066 | 117890 | 1 |
0.070 | 6009 | 1 |
0.074 | 73026 | 1 |
0.075 | 335646 | 1 |
Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |